Hypersoniq has successfully raised €1.1 million in funding to accelerate its growth and enhance its innovative Electrochemical Impedance Spectroscopy technology.

Information on the Target

Hypersoniq, founded in 2020 and based in Delft, Netherlands, has developed a cutting-edge technology known as Electrochemical Impedance Spectroscopy (EIS). This innovative method investigates the electrochemical properties of liquids by applying an alternating current signal across a range of frequencies. As a result, EIS produces a distinct Fluid Fingerprint Spectrum that encapsulates vast amounts of data regarding the analyzed fluid.

Utilizing advanced analytical techniques, Hypersoniq is able to deconvolute this data, extracting meaningful insights to address customer-specific challenges. This proprietary technology positions Hypersoniq as a leader in the field, offering unique solutions for various sectors that require in-depth fluid analysis.

Industry Overview in the Netherlands

The Netherlands has a dynamic technology landscape, particularly in the field of analytical science and engineering. With a strong emphasis on research and development, the country is at the forefront of innovati

View Source

Similar Deals

NAP (formerly Cavalry Ventures) beSirius

2025

Seed Stage Specialty Mining & Metals (NEC) Netherlands
Borski Fund CarbonX

2024

Seed Stage Specialty Chemicals (NEC) Netherlands
Chrysalix Venture Capital C2CA Technology

2023

Seed Stage Cement & Concrete Manufacturing Netherlands
Capital Mills Cloudprinter.com

2023

Seed Stage Paper Products (NEC) Netherlands
SHIFT Invest GreenA

2023

Seed Stage Pesticides Netherlands

VP Capital

invested in

Hypersoniq

in 2023

in a Seed Stage deal

Disclosed details

Transaction Size: $1M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert